Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification

22 Aug 2023

Abstract excerpt

Angiotensin-converting enzyme 2 (ACE2), a counter regulator of the renin-angiotensin system, provides protection against several chronic diseases. Besides chronic diseases, ACE2 is the host receptor for SARS-CoV or SARS-CoV-2 virus, mediating the first step of virus infection. ACE2 levels are regulated by transcriptional, post-transcriptional, and post-translational regulation or modification. ACE2 transcription...

Source

Identifiers

PMID: 37608279
DOI: 10.1186/s12929-023-00965-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ACE2 in chronic disease and COVID-19: gene regulation and post-translational modificationPMID 37608279Read ↗

A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible TargetsSemantic proximity Read ↗

A computational and bioinformatic analysis of ACE2: an elucidation of its dual role in COVID-19 pathology and finding its associated partners as potential therapeutic targetsSemantic proximity Read ↗

ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19Semantic proximity Read ↗

Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?Semantic proximity Read ↗

Variants in ACE2; potential influences on virus infection and COVID-19 severity.Semantic proximity Read ↗

SARS-CoV-2, ACE2 expression, and systemic organ invasionSemantic proximity Read ↗

Intronic regulation of SARS-CoV-2 receptor (ACE2) expression mediated by immune signaling and oxidative stress pathwaysSemantic proximity Read ↗

The emerging role of ACE2 in physiology and diseaseSemantic proximity Read ↗

Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugsSemantic proximity Read ↗

Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses.Semantic proximity Read ↗

ACE2 in the Era of SARS-CoV-2: Controversies and Novel PerspectivesSemantic proximity Read ↗

ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID‐19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.